TWI370741B - Stable liquid compositions for treating stomatitis comprising epidermal growth factor - Google Patents

Stable liquid compositions for treating stomatitis comprising epidermal growth factor

Info

Publication number
TWI370741B
TWI370741B TW096137828A TW96137828A TWI370741B TW I370741 B TWI370741 B TW I370741B TW 096137828 A TW096137828 A TW 096137828A TW 96137828 A TW96137828 A TW 96137828A TW I370741 B TWI370741 B TW I370741B
Authority
TW
Taiwan
Prior art keywords
growth factor
epidermal growth
liquid compositions
stable liquid
treating stomatitis
Prior art date
Application number
TW096137828A
Other languages
English (en)
Other versions
TW200824719A (en
Inventor
Sun-Hee Kim
Lee Sang-Kil
Chae-Ha Yoon
Sun-Mee Yang
Sang-Hyun Nam
Kyeong-Sun Shin
Seung-Kook Park
Sang-Wook Lee
Original Assignee
Daewoong Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Co Ltd filed Critical Daewoong Co Ltd
Publication of TW200824719A publication Critical patent/TW200824719A/zh
Application granted granted Critical
Publication of TWI370741B publication Critical patent/TWI370741B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1808Epidermal growth factor [EGF] urogastrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/485Epidermal growth factor [EGF] (urogastrone)
TW096137828A 2006-10-09 2007-10-09 Stable liquid compositions for treating stomatitis comprising epidermal growth factor TWI370741B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060097734A KR100784134B1 (ko) 2006-10-09 2006-10-09 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물

Publications (2)

Publication Number Publication Date
TW200824719A TW200824719A (en) 2008-06-16
TWI370741B true TWI370741B (en) 2012-08-21

Family

ID=39140442

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096137828A TWI370741B (en) 2006-10-09 2007-10-09 Stable liquid compositions for treating stomatitis comprising epidermal growth factor

Country Status (8)

Country Link
US (1) US9155697B2 (zh)
EP (1) EP2083797A4 (zh)
JP (1) JP2010505942A (zh)
KR (1) KR100784134B1 (zh)
CN (1) CN101541305B (zh)
MY (1) MY144321A (zh)
TW (1) TWI370741B (zh)
WO (1) WO2008044852A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100190735A1 (en) * 2006-03-28 2010-07-29 Myrex Pharmaceuticals Inc. Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis
US8221994B2 (en) * 2009-09-30 2012-07-17 Cilag Gmbh International Adhesive composition for use in an immunosensor
AU2012202981B2 (en) * 2009-09-30 2014-01-23 Cilag Gmbh International Adhesive Composition for Use in an Immunosensor
WO2015077227A1 (en) 2013-11-19 2015-05-28 Aqua Metals Inc. Devices and methods for smelterless recycling of lead acid batteries
EP3294929B1 (en) 2015-05-13 2021-04-14 Aqua Metals Inc. Closed loop systems and methods for recycling lead acid batteries
US10689769B2 (en) 2015-05-13 2020-06-23 Aqua Metals Inc. Electrodeposited lead composition, methods of production, and uses
KR102274210B1 (ko) 2015-05-13 2021-07-06 아쿠아 메탈스 인크. 납산 배터리로부터 납의 회수를 위한 시스템 및 방법들
US10316420B2 (en) 2015-12-02 2019-06-11 Aqua Metals Inc. Systems and methods for continuous alkaline lead acid battery recycling
JP7183268B2 (ja) * 2017-11-20 2022-12-05 ジャスト-エヴォテック バイオロジックス、インコーポレイテッド 等張化剤としてリジン塩を含有するアフリベルセプト製剤及びその使用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717717A (en) 1986-11-05 1988-01-05 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
NZ235556A (en) 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US5705485A (en) * 1987-09-18 1998-01-06 Ethicon, Inc. Gel formulations containing growth factors
US5102870A (en) 1989-04-14 1992-04-07 Schering Ag Treatment and prevention of oral mucositis with growth factors
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5272135A (en) * 1991-03-01 1993-12-21 Chiron Ophthalmics, Inc. Method for the stabilization of methionine-containing polypeptides
EP0648113A4 (en) 1992-04-23 1996-12-04 Berlex Lab BIOADHAESIVE FIXED MINERAL OIL EMULSION.
KR960013439B1 (ko) 1993-04-26 1996-10-05 주식회사 대웅제약 안정한 상피세포 성장인자(egf) 조성물
SE9400036D0 (sv) 1994-01-10 1994-01-10 Pharmacia Ab Low modecular weight hyaluronic acid
US5580856A (en) 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
TW518219B (en) * 1996-04-26 2003-01-21 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
WO1999009992A1 (fr) * 1997-08-27 1999-03-04 Yoshitomi Pharmaceutical Industries, Ltd. Promoteurs de neovascularisation
JP2001526239A (ja) 1997-12-22 2001-12-18 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド 角質細胞増殖因子−2製剤
JP2000056344A (ja) * 1998-06-05 2000-02-25 Fuji Xerox Co Ltd 光導波路素子およびその製造方法
WO2000056344A1 (fr) 1999-03-24 2000-09-28 Seikagaku Corporation Salive artificielle
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
AU1979201A (en) * 1999-12-09 2001-06-18 Bio Syntech Canada Inc Mineral-polymer hybrid composition
KR100366439B1 (ko) 2000-02-21 2003-01-09 주식회사 대웅 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물
JP5058404B2 (ja) * 2000-07-03 2012-10-24 株式会社シリウス スロットマシン
US7998929B2 (en) 2000-09-01 2011-08-16 Chugai Seikyaku Kabushiki Kaisha Solution preparations stabilized over long time
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
JP2002255852A (ja) * 2001-03-01 2002-09-11 Toa Eiyo Ltd 口内炎用スプレー製剤
CN1129452C (zh) 2001-04-10 2003-12-03 王非 表皮生长因子口含片
US7202066B2 (en) 2002-01-29 2007-04-10 Carrington Laboratories, Inc. Combination of a growth factor and a protease enzyme
WO2004028557A1 (ja) 2002-09-26 2004-04-08 Shionogi & Co., Ltd. 安定化されたタンパク組成物
US20060193783A1 (en) 2003-02-17 2006-08-31 Bhowmick Balaram S Low dose corticosteroid composition
EP1532983A1 (en) * 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
KR20050055858A (ko) 2003-12-09 2005-06-14 주식회사 엘지생활건강 구강 약물 전달 시스템
FI20041425A0 (fi) 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
ES2504441T3 (es) * 2004-12-15 2014-10-08 Swedish Orphan Biovitrum Ab (Publ) Formulaciones terapéuticas del factor de crecimiento de queratinocitos
SG161209A1 (en) 2004-12-22 2010-05-27 Ambrx Inc Formulations of human growth hormone comprising a non-naturally encoded amino acid
CA2600836A1 (en) * 2005-03-08 2006-09-14 Pharmacia & Upjohn Company Llc Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent
WO2008088922A2 (en) * 2007-01-19 2008-07-24 Genentech, Inc. Prevention of hydrogel viscosity loss

Also Published As

Publication number Publication date
EP2083797A4 (en) 2012-10-31
CN101541305A (zh) 2009-09-23
US20100035809A1 (en) 2010-02-11
JP2010505942A (ja) 2010-02-25
EP2083797A1 (en) 2009-08-05
WO2008044852A1 (en) 2008-04-17
TW200824719A (en) 2008-06-16
MY144321A (en) 2011-08-29
CN101541305B (zh) 2012-04-11
KR100784134B1 (ko) 2007-12-12
US9155697B2 (en) 2015-10-13

Similar Documents

Publication Publication Date Title
HUS2300001I1 (hu) Készítmények és alkalmazások szklerózis multiplex kezelésére
TWI370741B (en) Stable liquid compositions for treating stomatitis comprising epidermal growth factor
EP2001460A4 (en) COMPOSITIONS FOR PROMOTING HAIR GROWTH
PL1975226T3 (pl) Płynna kompozycja do obróbki
PL2193133T3 (pl) Imidazolotiadiazole do stosowania jako inhibitory kinazy białkowej
EP2242437A4 (en) PROSTHESIS OF FACETARY FASTENING
HK1205961A1 (zh) 用於骨生長的包含鍶化合物的纖維蛋白組合物
ZA201104396B (en) "substituted isoidoles as bace inhibitors and their use (new compounds 578)"
EP2043621A4 (en) TREATMENT OF CANCER BY MODULATION OF PROTEIN KINASE USING HEXAHYDRO-ISOALPHA ACIDS
EP2120561A4 (en) COMPOSITIONS FOR TREATING BIOFILMS, AND METHODS FOR THEIR USE
EP2008545A4 (en) APPLICATOR FOR LIQUID
EP2066174A4 (en) COMPOSITIONS WITH ALPHA-1-ANTITRYPINE AND METHOD OF USE THEREOF
EP1977733A4 (en) LIQUID COSMETICS
EP2028964A4 (en) CONTAINER FOR COSMETIC PRODUCT
ZA200900807B (en) Isoserine derivatives for use as coagulation factor IXa inhibitors
GB0813040D0 (en) Compositions for use as or in wound dressings
ZA200903771B (en) Carbamate compounds for use in treating depression
EP1858841A4 (en) STERILIZING COMPOSITION CONTAINING W-ALKOXYPEROXY CARBOXYLIC ACID
EP2384350A4 (en) PROCESS FOR PREPARING ORGANOZIN SALTS AND COMPOSITIONS THEREWITH
EP2174956A4 (en) COMPOSITIONS FOR ANTIFIBRINOLYSIS THERAPY
GB0619816D0 (en) Novel interferon-alpha constructs for use in the treatment of cancer
IL197505A0 (en) TARTRATE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS
EP2019819A4 (en) INNOVATIVE PEPTIDE DERIVATIVES AS ANTIMICROBIAL AGENTS FOR THE TREATMENT OF INJURIES
IL208624A0 (en) Compositions for the treatment of lice
GB0622847D0 (en) Cosmetic composition